Restor Metabolix Of Columbus - Medicare Primary Care in Columbus, GA

Restor Metabolix Of Columbus is a medicare enrolled primary clinic (Clinic/center) in Columbus, Georgia. The current practice location for Restor Metabolix Of Columbus is 1005 Talbotton Rd Ste B, Columbus, Georgia. For appointments, you can reach them via phone at (706) 580-7871. The mailing address for Restor Metabolix Of Columbus is Po Box 2102, Carrollton, Georgia and phone number is () -.

Restor Metabolix Of Columbus is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1154036929. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (706) 580-7871.

Contact Information

Restor Metabolix Of Columbus
1005 Talbotton Rd Ste B
Columbus
GA 31904-8763
(706) 580-7871
Not Available

Primary Care Clinic Profile

Full NameRestor Metabolix Of Columbus
SpecialityClinic/Center
Location1005 Talbotton Rd Ste B, Columbus, Georgia
Authorized Official Name and PositionPamela Melissa Hood (REVENUE CYCLE DIRECTOR)
Authorized Official Contact9125902184
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Restor Metabolix Of Columbus
Po Box 2102
Carrollton
GA 30112-0039

Ph: () -
Restor Metabolix Of Columbus
1005 Talbotton Rd Ste B
Columbus
GA 31904-8763

Ph: (706) 580-7871

NPI Details:

NPI Number1154036929
Provider Enumeration Date01/17/2023
Last Update Date02/27/2023

Medicare PECOS Information:

Medicare PECOS PAC ID8527424134
Medicare Enrollment IDO20230523002245

News Archive

Researchers receive grants to study genetics of contact-lens wearers with and without MK

More than 125 million people worldwide wear contact lenses, and while many are exposed to relatively common bacteria through their contact lenses, not all contract an eye infection.

Alere declares $3.00 per share dividend on Series B stock

Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

New therapy for transplant rejection

Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.

Read more Medical News

› Verified 8 days ago

Medical Identifiers

Medical identifiers for Restor Metabolix Of Columbus such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154036929NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261Q00000XClinic/center (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Restor Metabolix Of Columbus acts as a billing entity for following providers:
Provider NameRicardo Alvarez
Provider TypePractitioner - Endocrinology
Provider IdentifiersNPI Number: 1417078031
PECOS PAC ID: 1759367436
Enrollment ID: I20080115000446

News Archive

Researchers receive grants to study genetics of contact-lens wearers with and without MK

More than 125 million people worldwide wear contact lenses, and while many are exposed to relatively common bacteria through their contact lenses, not all contract an eye infection.

Alere declares $3.00 per share dividend on Series B stock

Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

New therapy for transplant rejection

Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.

Read more Medical News

› Verified 8 days ago

Provider NameRandall Crawford Jr
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1740678739
PECOS PAC ID: 6901124858
Enrollment ID: I20150406001498

News Archive

Researchers receive grants to study genetics of contact-lens wearers with and without MK

More than 125 million people worldwide wear contact lenses, and while many are exposed to relatively common bacteria through their contact lenses, not all contract an eye infection.

Alere declares $3.00 per share dividend on Series B stock

Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

New therapy for transplant rejection

Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.

Read more Medical News

› Verified 8 days ago

Provider NameCourtney Lofton Hayes
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1043874050
PECOS PAC ID: 4981937927
Enrollment ID: I20190606002535

News Archive

Researchers receive grants to study genetics of contact-lens wearers with and without MK

More than 125 million people worldwide wear contact lenses, and while many are exposed to relatively common bacteria through their contact lenses, not all contract an eye infection.

Alere declares $3.00 per share dividend on Series B stock

Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

New therapy for transplant rejection

Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.

Read more Medical News

› Verified 8 days ago

Provider NameEmily Ramsey
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1023745973
PECOS PAC ID: 6800256058
Enrollment ID: I20230719001728

News Archive

Researchers receive grants to study genetics of contact-lens wearers with and without MK

More than 125 million people worldwide wear contact lenses, and while many are exposed to relatively common bacteria through their contact lenses, not all contract an eye infection.

Alere declares $3.00 per share dividend on Series B stock

Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

New therapy for transplant rejection

Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.

Read more Medical News

› Verified 8 days ago

News Archive

Researchers receive grants to study genetics of contact-lens wearers with and without MK

More than 125 million people worldwide wear contact lenses, and while many are exposed to relatively common bacteria through their contact lenses, not all contract an eye infection.

Alere declares $3.00 per share dividend on Series B stock

Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

New therapy for transplant rejection

Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.

Read more News

› Verified 8 days ago


Clinic/Center in Columbus, GA

Family Wellcare Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4215 Woodruff Rd, Columbus, GA 31904
Phone: 706-653-6080    Fax: 706-653-6052
One On One Staffing &wellness Clinic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1315 Delauney Ave Ste 201-a, Columbus, GA 31901
Phone: 334-655-0315    
Gabiana Medical Offices
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 700 Center St, 201 Professional Tower, Columbus, GA 31901
Phone: 706-323-4747    Fax: 706-660-0676
Mac - Macon Road Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 3465 Macon Rd Ste D, Columbus, GA 31907
Phone: 706-243-3051    
Columbus Primary Care Internal Medicine Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1041 Talbotton Rd, Columbus, GA 31904
Phone: 706-660-8825    Fax: 706-660-8897
Unitehere Union Health & Wellness Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1110 Farr Rd Ste C, Columbus, GA 31907
Phone: 706-683-0909    Fax: 706-683-9757
Novela Health Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6901 Ray Wright Way Ste D, Columbus, GA 31909
Phone: 404-543-9924    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.